Federal award
CEPHEID
W81K0218P0315
Contract
Obligated and Ceiling
- Obligated (net)
- $1,088,336.70
- Ceiling (potential value, not spending)
- $1,088,336.70
- Current value
- $1,088,336.70
- Gross positive obligations
- $1,624,288.80
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CEPHEID · W6HQTMWB9Q28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- DANAHER CORPORATION · MBFSJ8M4RQB6
- Awarding agency
- Department of War · sub-agency 2100 · office W81K02
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0218P0315
- Award type code
- B
- Actions
- 12 · Sep 24, 2018 to Sep 17, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 17, 2021 | FY2021 | P00012 | B | −$229,331.70 | — |
| Nov 3, 2020 | FY2021 | P00011 | C | $447,115.20 | — |
| Oct 21, 2020 | FY2021 | P00010 | B | $0.00 | — |
| Sep 28, 2020 | FY2020 | P00008 | B | −$267,050.90 | — |
| Sep 28, 2020 | FY2020 | P00009 | B | $0.00 | — |
| May 13, 2020 | FY2020 | P00007 | G | $0.00 | — |
| Mar 23, 2020 | FY2020 | P00006 | B | $214,998.00 | — |
| Oct 29, 2019 | FY2020 | P00005 | C | $447,115.20 | — |
| Jul 17, 2019 | FY2019 | P00004 | G | $0.00 | — |
| Jul 15, 2019 | FY2019 | P00003 | B | −$39,569.50 | — |
| Oct 12, 2018 | FY2019 | P00001 | C | $515,060.40 | — |
| Sep 24, 2018 | FY2018 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.